Vincere Biosciences
PrivateLast Round
Grant
Nov 18, 2025
Total Funding Raised
$7.25M
Company Overview
Vincere Biosciences is a biotechnology company that develops small molecule therapeutics to treat age-related diseases, such as Parkinson's, by enhancing mitochondrial quality control.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vincere Biosciences Comps
Public and private peers based on sector, stage, and business model.
Vincere Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 18, 2025 | ||||
| Grant | Sep 25, 2023 | ||||
| Seed | Jun 12, 2023 | ||||
| Grant | Jun 1, 2022 | ||||
| Grant | Apr 13, 2020 | ||||
Grant | May 1, 2019 |
Vincere Biosciences Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Secured $5M in grant funding.
Vincere Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vincere Biosciences's valuation, stock price, and market status.
